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Abstract
Background: In cancer cells the three-dimensional (3D) telomere organization of interphase nuclei into a telomeric disk
is heavily distorted and aggregates are found. In Hodgkin’s lymphoma quantitative FISH (3D Q-FISH) reveals a major
impact of nuclear telomere dynamics during the transition form mononuclear Hodgkin (H) to diagnostic multinuclear
Reed-Sternberg (RS) cells. In vitro and in vivo formation of RS-cells is associated with the increase of very short telomeres
including “t-stumps”, telomere loss, telomeric aggregate formation and the generation of “ghost nuclei”.
Results: Here we analyze the 3D telomere dynamics by Q-FISH in the novel Hodgkin cell line U-HO1 and its
non-receptor protein-tyrosine phosphatase N1 (PTPN1) stable transfectant U-HO1-PTPN1, derived from a primary
refractory Hodgkin’s lymphoma. Both cell lines show equally high telomerase activity but U-HO1-PTPN differs from
U-HO1 by a three times longer doubling time, low STAT5A expression, accumulation of RS-cells (p < 0.0001) and a
fourfold increased number of apoptotic cells.
As expected, multinuclear U-HO1-RS-cells and multinuclear U-HO1-PTPN1-RS-cells differ from their mononuclear
H-precursors by their nuclear volume (p < 0.0001), the number of telomeres (p < 0.0001) and the increase in telo-
mere aggregates (p < 0.003). Surprisingly, U-HO1-RS cells differ from U-HO1-PTPN1-RS-cells by a highly significant
increase of very short telomeres including “t-stumps” (p < 0.0001).
Conclusion: Abundant RS-cells without additional very short telomeres including “t-stumps”, high rate of apoptosis,
but low STAT5A expression, are hallmarks of the U-HO1-PTPN1 cell line. These characteristics are independent of
telomerase activity. Thus, PTPN1 induced dephosphorylation of STAT5 with consecutive lack of Akt/PKB activation
and cellular arrest in G2, promoting induction of apoptosis, appears as a possible pathogenetic mechanism
deserving further experimental investigation.
Background
The bi- or multinuclear Reed-Sternberg cells (RS-cells),
t h ed i a g n o s t i cc e l l so fH o d g k i n ’sl y m p h o m a( H L ) ,a r e
derived from their mononuclear precursors, the Hodg-
kin cells (H-cell) through endoreplication and have a
limited capacity to divide further [1-3]. RS-cells appear
to be true end-stage tumour cells and their number of
nuclei correlates closely with the 3D organization of
telomeres [4]. Using a recently developed three-
dimensional quantitative fluorescent in situ hybridiza-
tion technique for telomere (3D telomere Q-FISH) [5]
we showed in vitro and in diagnostic biopsies that
further nuclear division becomes likely impossible
because of sustained telomere shortening, loss, aggrega-
tion and formation of telomere- and DNA-poor “ghost”
nuclei [6]. This process is identified in both, classical
EBV-negative and EBV-positive HL [6].
The recently established Hodgkin cell line U-HO1,
derived from a patient with primary refractory HL of
nodular sclerosis subtype, is EBV negative, expresses
* Correspondence: hans.knecht@USherbrooke.ca
1Division d’Hématologie, CHUS, Université de Sherbrooke, Sherbrooke,
Québec, Canada
Full list of author information is available at the end of the article
Knecht et al. BMC Cell Biology 2010, 11:99
http://www.biomedcentral.com/1471-2121/11/99
© 2010 Knecht et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.CD15 together with CD30 and has a clonal non-
functional VDJ-heavy gene rearrangement (Mader et al.,
2007). U-HO1 expresses a truncated and non functional
form of the non-receptor protein-tyrosine phosphatase
PTPN1, has a doubling time of about 4 days under stan-
dard culture conditions and forms about 4% of typical
RS-cells in suspension [7,8]. Stable expression of PTPN1
in U-HO1 (U-HO1-PTPN1) results in very slow prolif-
eration, substantially increased (about 4 x) RS-cell
formation and higher levels of apoptosis [8].
PTPN1 (also called PTP1B) specifically deactivates
phosphorylated STAT5A and STAT5B [9] which regu-
lates self-renewal capacity and differentiation of memory
B-cells [10]. Phosphorylated STAT5A is highly expressed
in all HL-cell lines analyzed so far [11], and its expression
is essential for morphogenesis of RS-cells [12]. PTPN1
-/-
mice show accumulation of large B-cells in bone marrow
and lymph nodes [13] as well as increased development
of inflammatory macrophages [14]. Moreover, double
knock out p53
-/- PTPN1
-/- mice rapidly develop B-cell
lymphomas [13]. These findings are consistent with a sig-
nificant influence of PTPN1 in B-cell lymphomagenesis
on an inflammatory background as present in HL [15].
In order to analyze the 3D nuclear telomere dynamics
associated with the transition from H- to RS-cells and
to clarify the functional role of PTPN1 expression in
this process, we analyzed by 3D telomere Q-FISH both,
mononuclear H-cells and multinuclear RS-cells of the
U-HO1 and the U-HO1-PTPN1 cell lines, respectively.
Results
Growth characteristics
T h eH Lc e l ll i n e sU - H O 1h a dad o u b l i n gt i m eo fa b o u t
3-4 days, and U-HO1-mock about 7 days, whereas
U-HO1-PTPN1 grew much slower with a doubling time
of about 14 days. In steady state culture, the number of
at least bi-nucleated RS-cells was about 4%-5% in both,
U-HO1 and U-HO1-mock, but significantly higher
(18-22%; p < 0.0001) in U-HO1-PTPN1 (Figure 1A, B).
Both cell lines, U-HO1 and U-HO1-PTPN1 had equally
high telomerase activity and in U-HO1-PTPN1 stable
expression of the specific protein-tyrosin-phosphatase
was confirmed by Western blotting (Figure 2A, B).
Stable expression of PTPN1 was associated with a high
apoptosis rate and had a significant impact on presence
of phosphorylated STAT5, which was high in U-HO1
but nearly absent in U-HO1-PTPN1 (Figure 3A, B).
3D nuclear organization of telomeres in Hodgkin cells of
U-HO1 and U-HO1-PTPN1
Mononuclear H-cells of U-HO1 and U-HO1-PTPN1
showed largely identical 3D telomere characteristics
(Figure 4 and Table 1). The only difference was a small
increase (p = 0.0407) of very short telomeres including
so-called “t-stumps” (Xu and Blackburn, 2007), occur-
ring in U-HO1 H-cells (Figure 4 and Table 1).
3D nuclear organization of telomeres in Reed-Sternberg
cells of U-HO1 and U-HO1-PTPN1
Reed-Sternberg cells of both, U-HO1 and U-HO1-
PTPN1, showed several common characteristics as pre-
viously identified in RS-cells of the HL cell lines
HDLM-2, L-428, L-1236 and patient biopsies [4,6]. As
expected, U-HO1-RS-cells and U-HO1-PTPN1 RS-cells
significantly differed from their mononuclear H-cell pre-
cursors by their nuclear volume (p < 0.0001), number of
telomeres (p < 0.0001) and increase of telomere aggre-
gates (p < 0.003). Strikingly, RS-cells of U-HO1 differed
from U-HO1-PTPN1-RS cells by a highly significant
increase in very short telomeres including so-called
“t-stumps” (p < 0.0001) (Table 1 Figure 5). RS-cells of
U-HO1 often showed numerous very short and short
telomeres without loss of mid-sized telomeres and stable
number of telomeres/1000 μm
3 of nuclear volume, con-
sistent with the hypothesis that these RS-cells were still
able to divide further through endoreplication, resulting
in giant RS-cells (Figure 6). Indeed, such telomere rich
U-HO1-RS cells were regularly identified and telomere-
poor or -free “ghost” nuclei were rare. Contrary to the
U-HO1 RS-cells, the PTPN1 expressing RS-cells did not
show any increase of very short telomeres (Figure 5 and
7) resulting in multinuclear RS-cells with a low number
of telomeres/1000 μm
3 of nuclear volume when com-
pared to their mononuclear H-precursors (p = 0.0175).
In such U-HO1-PTPN1 expressing RS-cells formation of
telomere-poor “ghost” nuclei was frequently observed.
Discussion
The Q-FISH analysis of the 3D nuclear telomere organi-
zation in the HL cell line U-HO1 reveals analogous
characteristics of multinuclear RS-cells compared to
their mononuclear precursor H-cells as recently
described in the HD-cell lines HDLM-2, L-428, L-1236
and in diagnostic biopsies of EBV-negative and LMP1-
expressing classical HL [4,6]. RS-cells of U-HO1 have a
3-4 times higher nuclear volume, a highly significant
increase of telomere aggregates, and a substantial
increase of very short telomeres, including so-called
“t-stumps”, a hallmark of cancer cells [16].
But contrary to the RS-cells of HDLM-2, L-428 and
L-1236, which show a significant loss of telomeres/1000
μm
3 of nuclear volume compared to their mononuclear
precursor H-cells, the RS-cells of U-HO1 show still the
same number of telomeres/1000 μm
3 of nuclear volume
as their mononuclear H-cell precursors, consistent not
only with a high telomerase activity but also with a still
functioning shelterin complex allowing correct telomere
elongation [17]. Indeed, U-HO1 is far less genetically
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Page 2 of 10Figure 1 PTPN1 expression promotes multinuclearity. Multinuclear RS-cells in U-HO1-mock (A) and U-HO1-PTPN1 (B). May-Grünwald-Giemsa
staining.
Figure 2 Telomerase activity and stable PTPN1 expression. A. TRAP assay shows equal telomerase activity in the HD-cell lines U-HO1 and
U-HO1-PTPN. Internal control of each sample after heat denaturation (ΔT +) demonstrates specificity. B. A strong specific band near 50 kDA is
observed in U-HO1-PTPN1 and in the positive control, the HD-cell line HDLM-2, whereas no signal is detected U-HO1 and U-HO1-mock.
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Page 3 of 10Figure 3 High apoptosis rate but low STAT5A expression in U-HO1-PTPN1. A. Apoptotic cells (M2), on the left to the G1 peak on the x-axis,
are about 4 times more frequent in U-HO1-PTPN1. B. Abundant phosphorylated STAT5A is present in the cytoplasm of U-HO1 mononuclear H-
and multinuclear RS-cells (left panel) but is barely present in U-HO1-PTPN1 (right panel). Note numerous bi- or multinucleated RS-cells in U-HO1-
PTPN1 but not in U-HO1.
Figure 4 3D nuclear staining of telomeres and total DNA of H-cells. A. Mononuclear U-HO1 H-cell (blue) shows few very short (arrows) but
mainly short and mid-sized telomeres (red) analogous to those identified in mononuclear U-HO1-PTPN1 H-cells (B).
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Page 4 of 10aberrant than other HL cell lines [18,19] but has about a
six-fold copy number gain of REL and a strong corre-
sponding nuclear c-REL protein localization, indicating a
high nuclear NF-B transcriptional activity [7] which is
required for proliferation and survival of H- and RS-cells
[20]. Phosphorylated STAT5, whose expression and acti-
vation is controlled by NF-B, and which is also required
for HL lymphomagenesis [12], is identified in the cyto-
plasm of H- and RS-cells in U-HO1 [[8], present study].
We hypothesize that the telomere dynamics identified
in U-HO1 reflect accumulation of phosphorylated
STAT5 resulting in permanent Akt/PKB (protein kinase
B) activation, for the following reasons: i) in HL accu-
mulation of phosphorylated STAT5 in H- and RS-is fre-
quent and possibly due to the expression of a mutated,
non functional SOCS-1 gene (suppressor of cytokine
signalling 1 gene) since single cell analysis of microdis-
sected H- and RS-cells from patient biopsies showed a
significant correlation between high nuclear phosphory-
lated STAT5 expression and SOCS-1 gene mutations
[21], ii) cytoplasmic accumulation of phosphorylated
STAT5 is identified in chronic and acute myeloid leuke-
mias and constitutive STAT5 activation promotes leuke-
mogenesis through cytoplasmic complex formation with
PI3-K/Gab2 resulting in Akt/PKB activation [22], iii)
activation of Akt/PKB is needed for G2/M transition
and may override a G2 arrest induced by DNA damage
[23]. This abrogation of the mitotic spindle cell-cycle
checkpoint leads indeed to polyploidization in vascular
smooth muscle cells transfected with Akt1 [24] and
might explain why some RS-cells of U-HO1 progress to
>8N DNA content through endoreplication while still
conserving a stable number of telomeres/1000 μm
3.
PTPN1 may exert tumor suppressing or tumor pro-
moting effects depending on the substrate involved and
the cellular context [25,26]. In the context of U-HO1,
stable expression of PTPN1 in the same cell line had
highly significant effects on slowing down the prolifera-
tion, on induction of apoptosis, and on increasing the
formation of RS-cells. These RS-cells had a significant
loss of the number of telomeres/1000 μm
3 of nuclear
volume but no increase in the number of very short
telomeres including “t-stumps” compared to the mono-
nuclear H-precursors. Thus, stable PTPN1 expression
was associated with dissociation of the reported 3D telo-
mere dynamics during RS-cell formation, resulting in
numerous RS-cells with a precursor H-cell 3D telomere
profile (Figure 5 and 7).
Since PTPN1 specifically deactivates phosphorylated
STAT5A and STAT5B [9] and stable expression of
siRNA targeting STAT5 slows down the proliferation of
L-428 and L-1236 cells by 200-300% [12], we hypothe-
size PTPN1 induced dephosphorylation of STAT5 in
U-HO1-PTPN1 cells to be the mechanism slowing
down the proliferation. In particular, the consecutive
lack of PI3-K/Gab2 and Akt/PKB activation needed for
G2/M transition might alleviate anti-apoptotic potential,
result in a G2 arrest induced by DNA damage [23] and
accumulation of end-stage RS-cells. The lack of any
increase of very short telomeres in U-HO1-PTPN1
Table 1 3D telomere characteristics of Hodgkin and Reed-Sternberg cells in U-HO1 and U-HO1-PTPN1
Cell type Parameter H-HO1 H-HO1-PTPN1 p-value
Hodgkin Total nuclear volume 4121 ± 1350 μm
3 3330 ± 844 μm
3 ns
Telomeres/cell (n)
(Total telomere volume)
53.8 ± 28.0 56.2 ± 19.9 ns
Telomeres/1000 μm
3
of nuclear volume (n)
14.0 ± 8.4 17.2 ± 6.1 ns
Telomere aggregates/cell (n) 6.0 ± 4.0 6.8 ± 4.2 ns
Cells with ≥ 20 telomere
aggregates (%)
2.9 2.8 ns
Very short telomeres
(< 5000 units; %)
21.2 18.3 0.0407
Reed-Sternberg Total nuclear volume 15301 ± 4641 μm
3 14839 ± 6722 μm
3 ns
Telomeres/cell (n)
(Total telomere volume)
123.0 ± 75.3 105.7 ± 62.7 ns
Telomeres/1000 μm
3
of nuclear volume (n)
13.7 ± 30.8 7.8 ± 4.0 ns
Telomere aggregates/cell (n) 13.8 ± 11.7 12.9 ± 10.5 ns
Cells with ≥ 20 telomere
aggregates (%)
17.2 13.8 ns
Very short telomeres
(< 5000 units; %)
23.4 13.8 < 0.0001
ns: p > 0.05.
Knecht et al. BMC Cell Biology 2010, 11:99
http://www.biomedcentral.com/1471-2121/11/99
Page 5 of 10RS-cells, contrary to the significant increase marking the
transition from H- to RS-cells in HDLM-2, L-1236, U-
HO1 and, most importantly, in patient biopsies, is con-
sistent with the induction of apoptosis by PTPN1
expression since induction of apoptosis does not change
the abundance of “t-stumps” in cancer cells [16].
Conclusions
Our Q-FISH analysis of the 3D telomere dynamics in
the HL cell lines U-HO1 and U-HO1-PTPN1 reveals
that stable PTPN1 expression is associated with i) low
proliferation rate, ii) increased number of RS-cells, iii)
induction of apoptosis, and iv) prevention of the addi-
tional formation of very short telomeres and “t-stumps”,
but not interfering with other 3D telomere dynamics
associated with RS-cell formation. Whether PTPN1
induced dephosphorylation of cytoplasmic STAT5 is at
the origin of these profound changes has to be
addressed by further experimental studies.
Methods
Cell lines
The cell lines U-HO1, U-HO1-PTPN1 and U-HO1-
mock were grown in suspension in 25 cm
2 culture flasks
in Iscove/RPMI-1640 medium (4:1) supplemented with
10% fetal calf serum, L-glutamine (2 mM), penicillin
(100 U/ml) and streptomycin (100 U/ml) in 5% CO2 in
a humidified atmosphere at 37
o C. U-HO1 and U-HO1-
mock were passed into new flasks containing fresh cul-
ture media twice weekly, U-HO1-PTPN1 once weekly,
due to much slower growth.
Generation of U-HO1-PTPN1
Plasmids were transfected into U-HO1 cells using the
Nucleofector device (Amaxa, Cologne, Germany). 2 ×
10
6 cells and 4 μg expression vector were used for each
plasmid nucleofection (Nucleofector Kit V, program
X-01). pcDNA4/TO vector was obtained from Invitro-
gen (Invitrogen, San Diego, CA) and used as a control
Figure 5 Telomere distribution according to size in U-HO1 and U-HO1-PTPN1. Results are based on 3D analysis of at least 30 H-cells and at
least 30 bi- or multinucleated RS cells. Grey line at 5000 U demarcates the border between very short telomeres including “t-stumps” and short
telomeres. U-HO1 RS-cells (clear blue) show significantly more (p < 0.0001) very short telomeres (0-5000 units) compared to U-HO1-PTPN1 RS-
cells (pink). U-HO1-PTPN1 RS-cells have nearly identical numbers of very short telomeres as U-HO1-PTPN1 H-cells consistent with the possibility
that PTPN1 expression abolished the formation very short telomeres including “t-stumps” during the transition from H- to RS-cells.
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Page 6 of 10mock-vector. The PTPN1 coding sequence (NM 003745,
nucleotide 155 to 790) was amplified by PCR on cDNA
from human tonsil and inserted into pcDNA4/TO vec-
tor under control of CMV promoter. The plasmids were
purified using Endofree Plasmid Purification MaxiKit
(Qiagen, Hilden, Germany). PTPN1 sequence was
checked by sequencing (MWG Biotech, Ebersberg,
Germany). Cells were harvested 24 h and 48 h post
transfection or after at least 4 weeks under zeocin selec-
tion for stable transfection. Success of stable transfection
was proved by immunoblotting against PTPN1.
TRAP assay
TRAP (Telomeric Repeat Amplification Protocol) was
performed using the TRAPeze Telomerase detection Kit
(S7700, Chemicon, Temecula, CA, USA). 100 ng of pro-
tein extract were subject to the TRAPeze procdure with
and without heat inactivation of telomerase (ΔT). Pic-
tures were shown as the negative of Ethidium bromide
coloration of a 10% PAGE (TBE 0.5X).
Apoptosis
Apoptosis was assessed by flow cytometry according to
the standard procedure of Nicoletti et al. [27].
Immunoblotting
For Western blotting 20 μgo fp r o t e i nw e r ec h a r g e dp e r
lane. The following primary antibodies were used:
PTPN1 (murine clone AE4-2J) (Merck, Darmstadt,
Germany), b-actin (murine clone AC-74), (Sigma, Dei-
senhofen, Germany). For detection peroxidase conju-
gated goat anti-rabbit IgG or goat anti-mouse IgG,
(Peribo Science, Bonn, Germany) was used. Signals were
visualized using the SuperSignal West Dura extended-
duration substrate (Perbio Science, Aalst, Belgium).
Immunocytology
Cytocentrifuge preparations of U-HO1 and and U-HO1-
PTPN1 cells were fixed in acetone (5 min), air dried,
and stained with MayGrünwald/Giemsa (MGG) accord-
ing to standard conditions. For the detection of
Figure 6 3D nuclear staining of telomeres and DNA in U-HO1 RS-cells. A. Representative 2D Z-stack image no. 36 out of 80 shows ring-like
multinuclear (blue) RS-cell composed of at least four nuclei of variable size. Arrow identifies a telomere group also shown in B and C. B. 3D
reconstruction in surface mode reveals abundant short and very short telomeres (red). C. Combined 3D nuclear staining confirms ring-like
nuclear configuration.
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Page 7 of 10phospho-STAT5, fresh cells of U-HO1 and U-HO1-
PTPN1 were collected, centrifuged, fixed in ethanol and
embed in paraffin. The specimen were cut in 5 μm thick
sectiones and further treated as usual. The primary
monoclonal antibody against phosphorylated STAT5
(Cell Signaling Technology, Beverly, MA) was diluted of
1:50 and used according to manufactorers instructions.
For detection the EnVision detection system (Dako,
Copenhagen, Denmark) was used and 3-Amino-9-ethyl-
carbazole served as the substrate.
Telomere Q-FISH
U-HO1 and U-HO1-PTPN1 cells were collected (200 × g
for 10 min) and resuspended in PBS containing 3.7% for-
maldehyde (Fluka) and incubated for 20 min. Thereafter,
the telomere Q-FISH protocol was performed [5,28] by
using Cy3-labelled PNA probes (DAKO). Imaging of
interphases after telomere FISH was performed by using
Zeiss AxioImager Z1 with a cooled AxioCam HR B & W,
DAPI, Cy3 filters in combination with a Planapo 63 ×/1.4
oil objective lens. Images were acquired by using AXIO-
VISION 4.6 (Zeiss) in multichannel mode followed by
constraint iterative deconvolution as specified below.
3D Image Acquisition
At least 30 H-cell interphase nuclei and at least 30 RS-
cell interphase polykaria were analyzed for both cell
lines. AXIOVISION 4.6 with deconvolution module and
rendering module were used. For every fluorochrome,
the 3D image consists of a stack of 80 images with a
sampling distance of 200 nm along the z and 107 nm in
the xy direction. The constrained iterative algorithm
option was used for deconvolution [29].
3D Image Analysis for Telomeres
Telomere measurements were done with TeloView TM
[30]. By choosing a simple threshold for the telomeres, a
binary image is found. Based on that, the center of grav-
ity of intensities is calculated for every object resulting
in a set of coordinates (x, y, z) denoted by crosses on
the screen. The integrated intensity of each telomere is
calculated because it is proportional to the telomere
length [31].
Telomere aggregates
Telomere aggregates are defined as clusters of telomeres
that are found in close association and cannot be further
Figure 7 3D nuclear staining of telomeres and DNA in U-HO1-PTPN1 RS-cells. A. Representative 2D Z-stack image no. 37 out of 80 shows a
tri-nuclear RS-cell composed of two large and one small telomere-poor “ghost” satellite nucleus. Arrow identifies a mid-sized telomere also
shown in B and C. B. 3D reconstruction in surface mode reveals relatively few (compared to cellular volume) mid-sized and short telomeres. Very
short telomeres including t-stumps are rare. C. Combined 3D nuclear staining confirms 3D telomere dynamics identical to those observed in
precursor H-cells (see Figure 4).
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Page 8 of 10resolved as separate entities at an optical resolution limit
of 200 nm [32].
Telomere length
Telomeres with a relative fluorescent intensity (y-axis)
ranging from 0-5000 units are classified as very short,
with an intensity ranging from 5,000-15,000 units as
short, with an intensity ranging from 15,000-30,000
units as mid-sized, and with an intensity >30,000 units
as large. The cut-off of 5,000 units is arbitrary and
based on our 5 years’ experience. Telomeres with an
intensity ≪ 5’000 are still easily identifiable on the Telo-
view-Program, but barely detectable on 3D reconstitu-
tion images.
Telomere volume
Total telomere volume is the sum of all very short,
short, mid-sized and large telomeres and aggregates
within one H- or RS-cell.
Nuclear volume
The Nuclear volume is calculated according to the 3D
nuclear 4’,6-diamidino-2-phenylindoline staining as
described earlier [33].
Statistical analysis
For both cell lines, normally distributed parameters are
compared between the two types of cells using nested
or two-way analysis of variance. Multiple comparisons
using the least-square means tests followed in which
interaction effects between two factors were found to be
significant. Other parameters that were not normally
distributed were compared using a non-parametric Wil-
coxon rank sum test. Significance levels were set at P =
0.05. Analyses were perfirmed using SAS v9.1 programs.
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